/enri-thumbnails/careeropportunities1f0caf1c-a12d-479c-be7c-3c04e085c617.tmb-mega-menu.jpg?Culture=en&sfvrsn=d7261e3b_1)
/cradle-thumbnails/research-capabilities1516d0ba63aa44f0b4ee77a8c05263b2.tmb-mega-menu.jpg?Culture=en&sfvrsn=1bc94f8_1)
7e6fdc03-9018-4d08-9a98-8a21acbc37ba.tmb-mega-menu.jpg?Culture=en&sfvrsn=7deaf618_1)
What is HOPE?
- First nationwide large-scale pragmatic four-arm (1:1:1:1) parallel cluster randomised control trial with General Practitioners in Singapore
- Study aim: To evaluate the effectiveness of three combinations of interventions in reducing the risk of cardiovascular disease (CVD) of individuals at risk of CVD in the primary care setting in Singapore
- Study duration: 6 months per participant
- Target number of participants: 1,500
- For information on the research study, click here
